Perspective Therapeutics (CATX) Other Non-Current Assets (2011 - 2026)

Perspective Therapeutics' (CATX) quarterly Other Non-Current Assets came in at $490000.0 in Q1 2026, up 33.88% year-on-year from $366000.0 in Q1 2025, and up 0.82% quarter-over-quarter from $486000.0 in Q4 2025.

Perspective Therapeutics (CATX) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Perspective Therapeutics has disclosed Other Non-Current Assets across 16 years of filings, most recently posting $490000.0 for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $490000.0, up 33.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $490000.0 (up 33.88% YoY), and the FY2025 annual result was $486000.0, up 20.0% from the prior year.
  • Other Non-Current Assets came in at $490000.0 for Q1 2026 at Perspective Therapeutics, up from $486000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $490000.0 in Q1 2026 to a low of $182000.0 in Q1 2022.
  • The 5-year median for Other Non-Current Assets is $182000.0 (2022), against an average of $267000.0.
  • Across the five-year window, Other Non-Current Assets changed 0.0% in 2022 and jumped 122.53% in 2024, its largest moves.
  • Perspective Therapeutics' Other Non-Current Assets stood at $182000.0 in 2022, then changed by 0.0% to $182000.0 in 2023, then surged by 122.53% to $405000.0 in 2024, then grew by 20.0% to $486000.0 in 2025, then climbed by 0.82% to $490000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $490000.0 (Q1 2026), $486000.0 (Q4 2025), and $438000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 3.17 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 4.04 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 738.90 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 828.89 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 285.90 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 2.25 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 211.40 Mn
10 Perspective Therapeutics 308.74 Mn 308.74 Mn - 490,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 490,000.00
Dec 31, 2025 486,000.00
Sep 30, 2025 438,000.00
Mar 31, 2025 366,000.00
Dec 31, 2024 405,000.00
Jun 30, 2024 182,000.00
Mar 31, 2024 182,000.00
Dec 31, 2023 182,000.00
Sep 30, 2023 182,000.00
Jun 30, 2023 182,000.00
Mar 31, 2023 182,000.00
Dec 31, 2022 182,000.00
Sep 30, 2022 182,000.00
Jun 30, 2022 182,000.00
Mar 31, 2022 182,000.00
Dec 31, 2021 182,000.00
Sep 30, 2021 182,000.00
Jun 30, 2021 130,000.00
Mar 31, 2021 182,000.00
Dec 31, 2020 182,000.00